Intraperitoneal (IP) port cytology after completion of primary therapy for advanced stage ovarian cancer: A novel approach to a "second look".

Affiliation

Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA. Electronic address: [Email]

Abstract

To determine whether IP port cytology predicts early recurrence and/or poor prognosis in patients with ovarian cancer who have completed primary therapy.

Keywords

IP port,Ovarian cancer,Overall survival,Port cytology,Progression free survival,Survival,

OUR Recent Articles